CORCEPT THERAPEUTICS INC
CORT · NASDAQ
Updated at 2026-10-14 09:52:58
- Today's High
- $122.80
- Today’s Low
- $117.42
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $121.24
- Previous Close
- $121.19
- Volume
- 497.73K
- Market Cap
- $13.1B
- P/E Ratio
- 237.76X
- EPS
- $0.42
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, UNITED STATES, 94065
- Country
- US
- Listing Date
- 2004-04-15
- Fiscal Year End
- December
- Shares Outstanding
- 108.1M
- CIK
- 0001088856
- Website
- www.corcept.com
Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States. The company is headquartered in Menlo Park, California.
Financial Metrics
Revenue
2026-06-30
$256.14M
2026-03-31
$164.9M
2025-12-31
$202.12M
2025-09-30
$207.63M
Operating Expenses
2026-06-30
$210.78M
2026-03-31
$211.62M
2025-12-31
$195.09M
2025-09-30
$192.82M
Net Income
2026-06-30
$42.14M
2026-03-31
-$31.2M
2025-12-31
$24.28M
2025-09-30
$19.66M
Net Profit Margin
2026-06-30
16.45%
2026-03-31
-18.92%
2025-12-31
12.01%
2025-09-30
9.47%
Earnings Per Share
2026-06-30
$0.36
2026-03-31
$-0.30
2025-12-31
$0.20
2025-09-30
$0.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$46.79M
2026-03-31
-$44.11M
2025-12-31
$10.39M
2025-09-30
$15.72M
Effective Tax Rate
2026-06-30
-6.4%
2026-03-31
30.22%
2025-12-31
-145.08%
2025-09-30
-29.02%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $256.14M | $164.9M | $202.12M | $207.63M |
| Operating Expenses | $210.78M | $211.62M | $195.09M | $192.82M |
| Net Income | $42.14M | -$31.2M | $24.28M | $19.66M |
| Net Profit Margin | 16.45% | -18.92% | 12.01% | 9.47% |
| Earnings Per Share | $0.36 | $-0.30 | $0.20 | $0.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $46.79M | -$44.11M | $10.39M | $15.72M |
| Effective Tax Rate | -6.4% | 30.22% | -145.08% | -29.02% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.